Office Management of Chronic Systolic Heart Failure

被引:1
作者
Geraci, Stephen A. [2 ]
Spencer, Jessie M. [2 ]
Stubbs, Nancy D. [1 ]
机构
[1] GV Sonny Montgomery VAMC, Med Serv 111, Jackson, MS 39216 USA
[2] Univ Mississippi, Sch Med, Dept Med, Jackson, MS USA
关键词
Chronic disease; Drug therapy; Heart failure; Medical management; Systolic;
D O I
10.1016/j.amjmed.2008.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence-based management of chronic systolic heart failure includes risk factor management, therapeutic lifestyle changes, and a polypharmaceutical regimen that prolongs survival, reduces or reverses progression of myocardial dysfunction, alleviates symptoms, and limits complications. Subspecialty consultation is warranted when symptoms progress despite standard therapy; interventions are needed for refractory coronary disease, an arrhythmia device is indicated, or surgical intervention or transplantation is considered.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 7 条
[1]  
ADAMS KF, 2006, HFSA 2006 COMPREHENS
[3]  
[Anonymous], 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI DOI 10.1001/JAMA.285.19.2486
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239
[6]  
MURRAY L, 2002, PHYS DESK REFERENCE
[7]  
Zipes DP., 2005, BRAUNWALDS HEART DIS, V7th